BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2097314)

  • 1. Modulation of experimental autoimmune uveitis with formosanin-C in guinea pigs.
    Wu RT; Lin WJ; Chiang HC; Horng LY; Chung YM
    J Ocul Pharmacol; 1990; 6(4):301-11. PubMed ID: 2097314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formosanin-C, an immunomodulator with antitumor activity.
    Wu RT; Chiang HC; Fu WC; Chien KY; Chung YM; Horng LY
    Int J Immunopharmacol; 1990; 12(7):777-86. PubMed ID: 2292459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulating effects of the hydrolysis products of formosanin C and beta-ecdysone from Paris formosana Hayata.
    Chiang HC; Wang JJ; Wu RT
    Anticancer Res; 1992; 12(5):1475-8. PubMed ID: 1444209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation of experimental autoimmune uveitis using a rat anti retinal S-antigen specific monoclonal antibody: evidence for a species difference.
    Dua HS; Liversidge J; Forrester JV
    Eye (Lond); 1989; 3 ( Pt 1)():69-78. PubMed ID: 2591601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide.
    Singh VK; Kalra HK; Yamaki K; Shinohara T
    Cell Immunol; 1992 Jan; 139(1):81-90. PubMed ID: 1728971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune uveitis in guinea pigs by ethylenediamine tetra-acetic acid, corticosteroids, and cyclosporin.
    Mahlberg K; Uusitalo H; Uusitalo R; Palkama A; Tallberg T
    J Ocul Pharmacol; 1987; 3(3):199-210. PubMed ID: 3141538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
    Nussenblatt RB; Caspi RR; Mahdi R; Chan CC; Roberge F; Lider O; Weiner HL
    J Immunol; 1990 Mar; 144(5):1689-95. PubMed ID: 2137841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-antigen: experimental autoimmune uveitis induced in guinea pigs with two synthetic peptides.
    Singh VK; Yamaki K; Donoso LA; Shinohara T
    Curr Eye Res; 1988 Jan; 7(1):87-92. PubMed ID: 3258805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral immune response to retinal S-antigen in patients with uveitis].
    Klass M; Böhnke M; Damms T; Knospe V
    Fortschr Ophthalmol; 1991; 88(5):450-4. PubMed ID: 1757030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A.
    Liversidge J; Thomson AW; Sewell HF; Forrester JV
    Clin Exp Immunol; 1987 Sep; 69(3):591-600. PubMed ID: 3478162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody levels to retinal S-antigen determined by ELISA in experimental and human uveitis.
    Chung YM; Wu RT; Lin WJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):83-96. PubMed ID: 2605975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRBP from bovine retina is poorly uveitogenic in guinea pigs and is identical to A-antigen.
    Vistica BP; Usui M; Kuwabara T; Wiggert B; Lee L; Redmond TM; Chader GJ; Gery I
    Curr Eye Res; 1987 Mar; 6(3):409-17. PubMed ID: 3581863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental autoimmune uveitis (EAU): immunophenotypic analysis of inflammatory cells in chorio retinal lesions.
    Liversidge J; Forrester JV
    Curr Eye Res; 1988 Dec; 7(12):1231-41. PubMed ID: 3229134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and biochemical properties of several retinal proteins bound by antibodies in sera from animals with experimental autoimmune uveitis and uveitis patients.
    Gregerson DS; Abrahams IW
    J Immunol; 1983 Jul; 131(1):259-64. PubMed ID: 6863917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis.
    Saoudi A; Hurez V; de Kozak Y; Kuhn J; Kaveri SV; Kazatchkine MD; Druet P; Bellon B
    Int Immunol; 1993 Dec; 5(12):1559-67. PubMed ID: 8312226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
    Sunil S; Eto K; Singh VK; Shinohara T
    Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific suppressor cells in experimental autoimmune uveitis.
    Rao NA; Atalla L; Fong SL; Chen F; Linker-Israeli M; Steinman L
    Ophthalmic Res; 1992; 24(2):92-8. PubMed ID: 1535119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveitopathogenic sites in bovine S-antigen.
    Singh VK; Donoso LA; Yamaki K; Shinohara T
    Autoimmunity; 1989; 3(3):177-87. PubMed ID: 2485082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.